[{“box”:0,”content”:”n[if 992 equals=”Open Access”]n
n
Open Access
nn
n
n[/if 992]n[if 2704 equals=”Yes”]n
nThis is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.n
n[/if 2704]n
n
n
nn
n
Vedant Patel, P. N. Vaishnavi, Himanshu Solanki, Jaimin Kumar Patel,
n t
n
n[/foreach]
n
n[if 2099 not_equal=”Yes”]n
- [foreach 286] [if 1175 not_equal=””]n t
- PG Research Scholar, PG Research Scholar, Professor, R&D, Department of Pharmaceutics, SSR College of Pharmacy, Department of Pharmaceutics, SSR College of Pharmacy, Department of Pharmaceutics, SSR College of Pharmacy, Navinta LLC, Dadra and Nagar Haveli and Daman and Diu,, Dadra and Nagar Haveli and Daman and Diu,, Dadra and Nagar Haveli and Daman and Diu,, Ewing, NJ 08628, India, India, India, USA
n[/if 1175][/foreach]
n[/if 2099][if 2099 equals=”Yes”][/if 2099]n
Abstract
n
n
nPharmaceutical beads are a unique and flexible drug delivery vehicle that provides numerous possibilities to control the release of drugs, protect them, and increase their therapeutic performance. These beads make it possible to design several types of therapeutic regimens by incorporating active pharmaceutical ingredients in a polymeric or lipid matrix. This review discusses the bead technology in drug delivery from its inception to its present application, focusing on the most important changes in bead formulation and their application in the invention of new drugs. Beads are the most significant in sustained and controlled release formulations, which are associated with better patient compliance and fewer side effects, and can be used in the treatment of patients in a more personalized way.nn
n
Keywords: Pharmaceutical beads, ionotropic gelation, spray drying, modified drug release, personalized medication.
n[if 424 equals=”Regular Issue”][This article belongs to Trends in Drug Delivery ]
n
n
n
n
nVedant Patel, P. N. Vaishnavi, Himanshu Solanki, Jaimin Kumar Patel. [if 2584 equals=”][226 wpautop=0 striphtml=1][else]Pharmaceutical Bead Formulations: A Comprehensive Overview into Advanced Drug Delivery[/if 2584]. Trends in Drug Delivery. 25/07/2025; 12(02):78-100.
n
nVedant Patel, P. N. Vaishnavi, Himanshu Solanki, Jaimin Kumar Patel. [if 2584 equals=”][226 striphtml=1][else]Pharmaceutical Bead Formulations: A Comprehensive Overview into Advanced Drug Delivery[/if 2584]. Trends in Drug Delivery. 25/07/2025; 12(02):78-100. Available from: https://journals.stmjournals.com/tdd/article=25/07/2025/view=0
nn
n
n[if 992 not_equal=”Open Access”]n
n
n[/if 992]n
nn
n
n
n
References n
n[if 1104 equals=””]n
1. Rajabi-Siahboomi AR. Overview of multiparticulate systems for oral drug delivery. In: Multiparticulate Drug Delivery: Formulation, Processing and Manufacturing. 2017. p. 1–4.
2. Ramu S, Ramakrishna G, Balaji M, Kondala K, Haranadh S, Kumar D. Multiple unit drug delivery system: pelletization techniques. Am J Adv Drug Deliv. 2013;1(1):11–21.
3. Lee S, Kim MS, Jun SW, Park JS, Hwang SJ. Preparation of controlled release spheronized beads by a simple extrusion and modified spheronization process. Arch Pharm Res. 2005;28:619–25.
4. Prezotti FG, Cury BS, Evangelista RC. Mucoadhesive beads of gellan gum/pectin intended to controlled delivery of drugs. Carbohydr Polym. 2014;113:286–95.
5. Goldman P. Herbal medicines today and the roots of modern pharmacology. Ann Intern Med. 2001;135(8 Pt 1):594–600.
6. Zuo J, Park C, Kung JY, Bou-Chacra NA, Doschak M, Löbenberg R. Traditional Chinese medicine “pill”, an ancient dosage form with surprising modern pharmaceutical characteristics. Pharm Res. 2021;38:199–211.
7. Advankar A, Maheshwari R, Tambe V, Todke P, Raval N, Kapoor D, et al. Specialized tablets: Ancient history to modern developments. In: Drug delivery systems. Academic Press; 2019. p. 615–64.
8. Helfand WH, Cowen DL. Evolution of pharmaceutical oral dosage forms. Pharm Hist. 1983;25(1):3–18.
9. Oudshoorn N. The male pill: A biography of a technology in the making. Durham: Duke University Press; 2003.
10. Helfand WH, Cowen DL. Evolution of pharmaceutical oral dosage forms. Pharm Hist. 1983;25(1):3–18.
11. Lee PI, Li JX. Evolution of oral controlled release dosage forms. In: Oral controlled release formulation design and drug delivery: Theory to practice. 2010. p. 21–31.
12. Qiu Y, Zhang G. Development of modified-release solid oral dosage forms. In: Developing Solid Oral Dosage Forms. Academic Press; 2009. p. 501–17.
13. Bose S, Bogner RH. Solventless pharmaceutical coating processes: A review. Pharm Dev Technol. 2007;12(2):115–31.
14. O’Connor RE, Schwartz JB. Extrusion and spheronization technology. In: Pharmaceutical Pelletization Technology. CRC Press; 2022. p. 187–216.
15. Foroughi-Dahr M, Mostoufi N, Sotudeh-Gharebagh R, Chaouki J. Particle coating in fluidized beds. Ref Modul Chem Mol Sci Chem Eng. 2017:1–89.
16. Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: Mechanisms of controlling drug release. Chem Rev. 2016;116(4):2602–63.
17. Desai D, Wang J, Wen H, Li X, Timmins P. Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms. Pharm Dev Technol. 2013;18(6):1265–76.
18. Seoane-Vazquez E, Rodriguez-Monguio R, Hansen R. Interchangeability, safety and efficacy of modified-release drug formulations in the USA: The case of opioid and other nervous system drugs. Clin Drug Investig. 2016;36:281–92.
19. Jinshad K, Pillai MK. Enteric coated effervescent micro bead drug delivery system: A better approach for pulsatile drug delivery to intestine. Res J Pharm Technol. 2019;12(8):4007–12.
20. Battaglia L, Ugazio E. Lipid nano‐ and microparticles: An overview of patent‐related research. J Nanomater. 2019;2019(1):2834941.
21. Alruwaili NK, Rizwanullah M, Bukhari SN, Amir M, Ahmed MM, Fazil M. 3D printing technology in design of pharmaceutical products. Curr Pharm Des. 2018;24(42):5009–18.
22. Kapoor D, Maheshwari R, Verma K, Sharma S, Ghode P, Tekade RK. Coating technologies in pharmaceutical product development. In: Drug Delivery Systems. Academic Press; 2020. p. 665–719.
23. Banker GS, Siepmann J, Rhodes C. Sustained-and controlled-release drug-delivery systems. In: Modern Pharmaceutics. CRC Press; 2002. p. 768–810.
24. Shamma RN, Basalious EB, Shoukri RA. Development and optimization of a multiple-unit controlled release formulation of a freely water-soluble drug for once-daily administration. Int J Pharm. 2011;405(1–2):102–12.
25. Tran PH, Tran TT, Park JB, Lee BJ. Controlled release systems containing solid dispersions: Strategies and mechanisms. Pharm Res. 2011;28:2353–78.
26. Abouelatta SM, Aboelwafa AA, Khalil RM, ElGazayerly ON. Floating lipid beads for the improvement of bioavailability of poorly soluble basic drugs: In-vitro optimization and in-vivo performance in humans. Eur J Pharm Biopharm. 2015;89:82–92.
27. Brahmankar DM, Jaiswal SB. Biopharmaceutics and Pharmacokinetics: Pharmacokinetics. 2nd ed. Delhi: Vallabh Prakashan; 2009. p. 399–401.
28. Lee VHL. Controlled Drug Delivery Fundamentals and Applications: Influence of Drug Properties on Design. 2nd ed. New York: Marcel Dekker Inc.; 1987. p. 16–25.
29. Wani MS, et al. Controlled release system – A review [Internet]. 2008 [cited 2025 Jun 25]. Available at http://www.pharmainfo.net/reviews/controlled-released-system-review
30. Ho WH, Lee HLV. Sustained Drug Delivery Fundamentals and Applications: Design and fabrication of oral controlled release drug delivery system. 2nd ed. Marcel Dekker Inc, New York: 1987; 373–420p.
31. Kar RK, Mohapatra S, Barik BB. Design and characterization of controlled release matrix tablets of Zidovudine. Asian J Pharm Clin Res. 2009;2:54–6.
32. Guthmann C, Lipp R, Wagner T, Kranz H. Development of a novel osmotically driven drug delivery system for weakly basic drugs. Eur J Pharm Biopharm. 2008;69(2):667–74.
33. Forbes ZG, Yellen BB, Barbee KA, Friedman G. An approach to targeted drug delivery based on uniform magnetic fields. IEEE Trans Magn. 2003;39(5):3372–7.
34. Shi J, Liu X, Sun X, Cao S. Hybrid alginate beads with thermal‐responsive gates for smart drug delivery. Polym Adv Technol. 2011;22(11):1539–46.
35. Jayakumar R, Reis RL, Mano JF. Synthesis and characterization of pH-sensitive thiol-containing chitosan beads for controlled drug delivery applications. Drug Deliv. 2007;14(1):9–17.
36. Martínez-Donato G, Piniella B, Aguilar D, Olivera S, Pérez A, Castañedo Y, et al. Protective T cell and antibody immune responses against hepatitis C virus achieved using a biopolyester-bead-based vaccine delivery system. Clin Vaccine Immunol. 2016;23(4):370–8.
37. Stöve J, Fiedler J, Huch K, Günther KP, Puhl W, Brenner R. Lipofection of rabbit chondrocytes and long lasting expression of a lacZ reporter system in alginate beads. Osteoarth Cartil. 2002;10(3):212–7.
38. Sharma KV, Dreher MR, Tang Y, Pritchard W, Chiesa OA, Karanian J, et al. Development of “imageable” beads for transcatheter embolotherapy. J Vasc Interv Radiol. 2010;21(6):865–76.
39. Rubin JP, Bennett JM, Doctor JS, Tebbets BM, Marra KG. Collagenous microbeads as a scaffold for tissue engineering with adipose-derived stem cells. Plast Reconstr Surg. 2007;120(2):414–24.
40. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res. 2003;59(2):277–87.
41. Mohanraj VJ, Chen YJ. Nanoparticles—a review. Trop J Pharm Res. 2006;5(1):561–73.
42. Chrai SS, Murari R, Ahmad I. Liposomes: A review. Pharm Technol. 2002;26(4):28–34.
43. Croy SR, Kwon GS. Polymeric micelles for drug delivery. Curr Pharm Des. 2006;12(36):4669–84.
44. Kulkarni AR, Soppimath KS, Aminabhavi TM, Dave AM, Mehta MH. Glutaraldehyde crosslinked sodium alginate beads containing liquid pesticide for soil application. J Control Release. 2000;63(1–2):97–105.
45. Bodmeier R, Oh KH, Pramar Y. Preparation and evaluation of drug-containing chitosan beads. Drug Dev Ind Pharm. 1989;15(9):1475–94.
46. Lopes S, Bueno L, Aguiar FD, Finkler C. Preparation and characterization of alginate and gelatin microcapsules containing Lactobacillus rhamnosus. An Acad Bras Cienc. 2017;89(3):1601–13.
47. Kim CJ, Lee PI. Composite poly(vinyl alcohol) beads for controlled drug delivery. Pharm Res. 1992;9:10–6.
48. Agarwal T, Kabiraj P, Narayana GH, Kulanthaivel S, Kasiviswanathan U, Pal K, et al. Alginate bead based hexagonal close packed 3D implant for bone tissue engineering. ACS Appl Mater Interfaces. 2016;8(47):32132–45.
49. Fu YC, Ho ML, Wu SC, Hsieh HS, Wang CK. Porous bioceramic bead prepared by calcium phosphate with sodium alginate gel and PE powder. Mater Sci Eng C. 2008;28(7):1149–58.
50. Quang DV, Sarawade PB, Hilonga A, Kim JK, Chai YG, Kim SH, et al. Preparation of amino functionalized silica microbeads by dry method for supporting silver nanoparticles with antibacterial properties. Colloids Surf A Physicochem Eng Asp. 2011;389(1–3):118–26.
51. Wang F, Zhao J, Li W, Zhou H, Yang X, Sui N, et al. Preparation of several alginate matrix gel beads and their adsorption properties towards rare earths (III). Wast Biom Valoriz. 2013;4:665–74.
52. Lugtu-Pe JA, Lin BY, Chen K, Ghaffari A, Kane A, Wu XY. Tailoring release profiles of BCS class II drugs using controlled release amorphous solid dispersion beads with membrane-reservoir design: Effect of pore former and coating levels. Mol Pharm. 2021;18(11):4198–209.
53. Lee BJ, Min GH. Preparation and release characteristics of polymer-reinforced and coated alginate beads. Arch Pharm Res. 1995;18:183–8.
54. Sriamornsak P. Application of pectin in oral drug delivery. Expert Opin Drug Deliv. 2011;8(8):1009–23.
55. Bayomi MA, El-Sayed YM. Casein microbeads as a controlled parenteral drug delivery system. Drug Dev Ind Pharm. 1994;20(16):2607–17.
56. Swain S, Behera A, Beg S, Patra CN, Dinda SC, Sruti J, et al. Modified alginate beads for mucoadhesive drug delivery system: An updated review of patents. Recent Pat Drug Deliv Formul. 2012;6(3):259–77.
57. Lam PL, Gambari R. Advanced progress of microencapsulation technologies: In vivo and in vitro models for studying oral and transdermal drug deliveries. J Control Release. 2014;178:25–45.
58. Koester M, Thommes M. New insights into the pelletization mechanism by extrusion/spheronization. AAPS PharmSciTech. 2010;11:1549–51.
59. Trivedi NR, Rajan MG, Johnson JR, Shukla AJ. Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process. Crit Rev Ther Drug Carrier Syst. 2007;24(1).
60. Dhandapani NV. Pelletization by extrusion-spheronization—a detailed review. All Results J Biol. 2012;3(2):10–23.
61. Jain SP, Pal Singh P, Amin PD. Alternative extrusion–spheronization aids. Drug Dev Ind Pharm. 2010;36(11):1364–76.
62. Ravetti S, Hergert LY, Sparo MD, Sanchez Bruni SF, Palma SD. Challenges in protein formulation focused on extrusion-spheronization process. Int J Pharm Res Rev. 2016;5(3):29–38.
63. Patil JS, Kamalapur MV, Marapur SC, Kadam DV. Ionotropic gelation and polyelectrolyte complexation: the novel techniques to design hydrogel particulate sustained, modulated drug delivery system: A review. Dig J Nanomater Biostruct. 2010;5(1):241–8.
64. Rakesh P, Vipin K, Kanchan K. Alginate beads prepared by ionotropic gelation technique: Formulation design. Res J Chem Sci. 2015;2231:606X.
65. Pedroso‐Santana S, Fleitas‐Salazar N. Ionotropic gelation method in the synthesis of nanoparticles/microparticles for biomedical purposes. Polym Int. 2020;69(5):443–7.
66. Sacco P, Pedroso-Santana S, Kumar Y, Joly N, Martin P, Bocchetta P. Ionotropic gelation of chitosan flat structures and potential applications. Molecules. 2021;26(3):660.
67. Santos D, Maurício AC, Sencadas V, Santos JD, Fernandes MH, Gomes PS. Spray drying: An overview. In: Biomaterials–Physics and Chemistry–New Edition. 2018:9–35.
68. Kemtchou VT, Schäfer M, Peuker UA. Synthesis of functionalized magnetic beads using spray drying. In: Upscaling of Bio-Nano-Processes: Selective Bioseparation by Magnetic Particles. Berlin: Springer; 2014. p. 97–116.
69. Okuyama K, Abdullah M, Lenggoro IW, Iskandar F. Preparation of functional nanostructured particles by spray drying. Adv Powder Technol. 2006;17(6):587–611.
70. Sosnik A, Seremeta KP. Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers. Adv Colloid Interface Sci. 2015;223:40–54.
71. Peighambardoust SH, Tafti AG, Hesari J. Application of spray drying for preservation of lactic acid starter cultures: A review. Trends Food Sci Technol. 2011;22(5):215–24.
72. Young CR, Koleng JJ, McGinity JW. Production of spherical pellets by a hot-melt extrusion and spheronization process. Int J Pharm. 2002;242(1–2):87–92.
73. Madan S, Madan S. Hot melt extrusion and its pharmaceutical applications. Asian J Pharm Sci. 2012;7(1).
74. Repka MA, Battu SK, Upadhye SB, Thumma S, Crowley MM, Zhang F, et al. Pharmaceutical applications of hot-melt extrusion: Part II. Drug Dev Ind Pharm. 2007;33(10):1043–57.
75. Andrews GP, Jones DS, Diak OA, Margetson DN, McAllister MS. Hot-melt extrusion: An emerging drug delivery technology. Pharm Technol Eur. 2009;21(1):18–24.
76. Verreck G, Vandecruys R, De Conde V, Baert L, Peeters J, Brewster ME. The use of three different solid dispersion formulations—melt extrusion, film-coated beads, and a glass thermoplastic system—to improve the bioavailability of a novel microsomal triglyceride transfer protein inhibitor. J Pharm Sci. 2004;93(5):1217–28.
77. Paradkar A, Maheshwari M, Tyagi AK, Chauhan B, Kadam SS. Preparation and characterization of flurbiprofen beads by melt solidification technique. AAPS PharmSciTech. 2003;4:514–22.
78. Maheshwari M, Ketkar AR, Chauhan B, Patil VB, Paradkar AR. Preparation and characterization of ibuprofen–cetyl alcohol beads by melt solidification technique: Effect of variables. Int J Pharm. 2003;261(1–2):57–67.
79. Kamble R, Maheshwari M, Paradkar A, Kadam S. Melt solidification technique: Incorporation of higher wax content in ibuprofen beads. AAPS PharmSciTech. 2004;5:75–83.
80. Sedighi M. Encapsulation: Melt dispersion. In: Principles of Biomaterials Encapsulation: Volume One. Woodhead Publishing; 2023. p. 213–34.
81. Becker K, Salar-Behzadi S, Zimmer A. Solvent-free melting techniques for the preparation of lipid-based solid oral formulations. Pharm Res. 2015;32:1519–45.
82. Prajapati VD, Jani GK, Khutliwala TA, Zala BS. Raft forming system—an upcoming approach of gastroretentive drug delivery system. J Control Release. 2013;168(2):151–65.
83. Aoki H, Iwao Y, Mizoguchi M, Noguchi S, Itai S. Clarithromycin highly-loaded gastro-floating fine granules prepared by high-shear melt granulation can enhance the efficacy of Helicobacter pylori eradication. Eur J Pharm Biopharm. 2015;92:22–7.
84. Patil H, Tiwari RV, Repka MA. Recent advancements in mucoadhesive floating drug delivery systems: A mini-review. J Drug Deliv Sci Technol. 2016;31:65–71.
85. Lohani A, Chaudhary G. Mucoadhesive microspheres: A novel approach to increase gastroretention. Chron Young Sci. 2012;3(2):121.
86. Sugihara H, Matsui Y, Takeuchi H, Wilding I, Connor A, Abe K, et al. Development of a gastric retentive system as a sustained-release formulation of pranlukast hydrate and its subsequent in vivo verification in human studies. Eur J Pharm Sci. 2014;53:62–8.
87. Garg RG, Gupta GD. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res. 2008;7(3):1055–66.
88. Wang J, Tauchi Y, Deguchi Y, Morimoto K, Tabata Y, Ikada Y. Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori. Drug Deliv. 2000;7(4):237–43.
89. Hilton AK, Deasy PB. In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate. Int J Pharm. 1992;86(1):79–88.
90. Manjunatha KM, Ramana MV, Satyanarayana D. Design and evaluation of diclofenac sodium controlled drug delivery systems. Indian J Pharm Sci. 2007;69(3):384–9.
91. Ganesh M, Jeon UJ, Ubaidulla U, Hemalatha P, Saravanakumar A, Peng MM, et al. Chitosan cocrystals embedded alginate beads for enhancing the solubility and bioavailability of aceclofenac. Int J Biol Macromol. 2015;74:310–7.
92. Rajesh AM, Popat KM. Taste masking of ofloxacin and formation of interpenetrating polymer network beads for sustained release. J Pharm Anal. 2017;7(4):244–51.
93. Puranam DH, Yarguntla SR, Pulipaka S. An empirical approach to mitigate the risk of content uniformity variability during the tablet compression of drug coated extended release beads. Nveo-Nat Volat Essent Oils J. 2021;8(4):15422–35.
94. Hirjau M, Nicoara AC, Hirjau V, Lupuleasa D. Pelletization techniques used in pharmaceutical fields. Pract Farm. 2011;4(3):206–11.
95. Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. Papain entrapment in alginate beads for stability improvement and site-specific delivery: Physicochemical characterization and factorial optimization using neural network modeling. AAPS PharmSciTech. 2005;6:E209–22.
96. Popa EG, Gomes ME, Reis RL. Cell delivery systems using alginate–carrageenan hydrogel beads and fibers for regenerative medicine applications. Biomacromolecules. 2011;12(11):3952–61.
97. Bhattacharya P. A review on the impacts of microplastic beads used in cosmetics. Acta Biomed Sci. 2016;3(1):47–52.
98. Sukhanova A, Nabiev I. Fluorescent nanocrystal-encoded microbeads for multiplexed cancer imaging and diagnosis. Crit Rev Oncol Hematol. 2008;68(1):39–59.
99. Martínez-Donato G, Piniella B, Aguilar D, Olivera S, Pérez A, Castañedo Y, et al. Protective T cell and antibody immune responses against hepatitis C virus achieved using a biopolyester-bead-based vaccine delivery system. Clin Vaccine Immunol. 2016;23(4):370–8.
100. Adebisi AO, Laity PR, Conway BR. Formulation and evaluation of floating mucoadhesive alginate beads for targeting Helicobacter pylori. J Pharm Pharmacol. 2015;67(4):511–24.
101. Vikulina AS, Campbell J. Biopolymer-based multilayer capsules and beads made via templating: Advantages, hurdles and perspectives. Nanomaterials (Basel). 2021;11(10):2502.
102. Saha S, Kaushik K, Garg R. Formulation of smart hydrogel beads for pharmaceutical importance. Res J Pharm Technol. 2020;13(2):901–4.
103. Moinuddin SK, Kumar P, Kumar S, Ramya P, Sree KS, Kavya K. A review on micro beads: Formulation, technological aspects, and extraction. GSC Biol Pharm Sci. 2024;26(2):59–66.
104. Mohamed MA, El-Deeb NM, El-Assar MR, Farag MM, Ahmed AF. Elusive pharmaceutical function of multi-advantages drug delivery system from natural mushroom. Al-Azhar Bull Sci. 2018;29(2-C):19–25.
105. Setia M, Kumar K, Teotia D. Gastro-retentive floating beads: A new trend of drug delivery system. J Drug Deliv Ther. 2018;8(3):169–80.
106. Burgos-Ramos E, Martos-Moreno GÁ, Argente J, Barrios V. Multiplexed bead immunoassays: Advantages and limitations in pediatrics. In: Advances in Immunoassay Technology. 2012. p. 165–80.
107. Ranganath SH, Kee I, Krantz WB, Chow PK, Wang CH. Hydrogel matrix entrapping PLGA-paclitaxel microspheres: Drug delivery with near zero-order release and implantability advantages for malignant brain tumour chemotherapy. Pharm Res. 2009;26:2101–14.
108. Jedinger N, Khinast J, Roblegg E. The design of controlled-release formulations resistant to alcohol-induced dose dumping–a review. Eur J Pharm Biopharm. 2014;87(2):217–26.
109. Hu L, Kong D, Hu Q, Yang X, Xu H. Preparation and optimization of a novel microbead formulation to improve solubility and stability of curcumin. Part Sci Technol. 2017;35(4):448–54.
110. Panahi HA, Feizbakhsh A, Khaledi S, Moniri E. Fabrication of new drug imprinting polymer beads for selective extraction of naproxen in human urine and pharmaceutical samples. Int J Pharm. 2013;441(1–2):776–80.
111. Villanova JC, Ayres E, Carvalho SM, Patrício PS, Pereira FV, Oréfice RL. Pharmaceutical acrylic beads obtained by suspension polymerization containing cellulose nanowhiskers as excipient for drug delivery. Eur J Pharm Sci. 2011;42(4):406–15.
112. Fernando PA, Kennedy AJ, Pokrzywinski K, Jernberg J, Thornell T, George G, et al. Development of alginate beads for precise environmental release applications: A design of experiment based approach and analysis. J Environ Manage. 2024;351:119872.
113. Zayed MS. Advances in formulation development technologies. In: Microbial Inoculants in Sustainable Agricultural Productivity: Vol. 2: Functional Applications. 2016:219–37.
114. Sriamornsak P, Nunthanid J, Cheewatanakornkool K, Manchun S. Effect of drug loading method on drug content and drug release from calcium pectinate gel beads. AAPS PharmSciTech. 2010;11:1315–9.
115. Singh G, Nenavathu BP. Development of rGO encapsulated polymeric beads as drug delivery system for improved loading and controlled release of doxycycline drug. Drug Dev Ind Pharm. 2020;46(3):462–70.
116. Ansari M, Sadarani B, Majumdar A. Colon targeted beads loaded with pterostilbene: Formulation, optimization, characterization and in vivo evaluation. Saudi Pharm J. 2019;27(1):71–81.
117. Rani M, Agarwal A, Negi YS. Chitosan based hydrogel polymeric beads–as drug delivery system. BioResources. 2010;5(4):2765–807.
118. RM A, Mangesh RB, Rahul RP, Nilkanth SP, Devaki CU. Formulation and optimization of drug-resin complex loaded mucoadhesive chitosan beads of repaglinide using factorial design. Am J Med Med Sci. 2012;2(4):62–70.
119. Jain SK, Jain A, Gupta Y, Ahirwar M. Design and development of hydrogel beads for targeted drug delivery to the colon. AAPS PharmSciTech. 2007;8(3):56.
120. Arica B, Çaliş SE, Atİlla PE, Durlu NT, Cakar N, Kaş HS, et al. In vitro and in vivo studies of ibuprofen-loaded biodegradable alginate beads. J Microencapsul. 2005;22(2):153–65.
121. Patil S, Sharma S, Nimbalkar A, Pawar A. Study of formulation variables on properties of drug-gellan beads by factorial design. Drug Dev Ind Pharm. 2006;32(3):315–26.
122. O’Brien MN, Jiang W, Wang Y, Loffredo DM. Challenges and opportunities in the development of complex generic long-acting injectable drug products. J Control Release. 2021;336:144–58.
123. Vino S, Paryani P, Ghosh AR. Formulation and evaluation of chitosan beads of levocetirizine dihydrochloride. J Appl Pharm Sci. 2012;2(8):221–5.
124. Sharma M. Formulation and evaluation of sodium alginate beads by emulsion gelation method. Asian J Pharm. 2017;11(1):101–6.
125. Mishra SK, Pathak K. Formulation and evaluation of oil entrapped gastroretentive floating gel beads of loratadine. Acta Pharm. 2008;58(2):187–97.
126. Tous S, Fathy M, Fetih G, Gad SF. Preparation and evaluation of ketoprofen-loaded calcium alginate beads. Int J PharmTech Res. 2014;6(3):1100–12.
127. Abdellatif AA, El Hamd MA, Saleh K. A formulation, optimization and evaluation of controlled released alginate beads loaded-flurbiprofen. J Nanomed Nanotechnol. 2016;7(357):2.
128. Li Y, Fan Y, Ma J. The thermal properties of porous polydivinylbenzene beads. React Funct Polym. 2002;50(1):57–65.
129. Neves MA, Coutinho FM, Dias ML, Simão RA, Achete CA. Surface morphology evaluation of polymer beads based on divinylbenzene by atomic force microscopy. J Appl Polym Sci. 2002;84(3):541–51.
130. Khan MS, Sridhar BK, Srinatha A. Development and evaluation of pH-dependent micro beads for colon targeting. Indian J Pharm Sci. 2010;72(1):18.
131. Thakur RS, Agrawal R. Application of nanotechnology in pharmaceutical formulation design and development. Curr Drug Ther. 2015;10(1):20–34.
132. Ahmadzadeh S, Ubeyitogullari A. Fabrication of porous spherical beads from corn starch by using a 3D food printing system. Foods. 2022;11(7):913.
133. Nofar M, Ameli A, Park CB. A novel technology to manufacture biodegradable polylactide bead foam products. Mater Des. 2015;83:413–21.
134. Ahmed MU, Saaem I, Wu PC, Brown AS. Personalized diagnostics and biosensors: A review of the biology and technology needed for personalized medicine. Crit Rev Biotechnol. 2014;34(2):180–96.
135. Janos B, Klara P, Odon P, Geza RJ, Rok D, Stane S, et al. Film coating as a method to enhance the preparation of tablets from dimenhydrinate crystals. Int J Pharm. 2004; 269:393–401.
nn[/if 1104][if 1104 not_equal=””]n
- [foreach 1102]n t
- [if 1106 equals=””], [/if 1106][if 1106 not_equal=””],[/if 1106]
n[/foreach]
n[/if 1104]
n
nn[if 1114 equals=”Yes”]n
n[/if 1114]
n
n
n
| Volume | 12 | |
| [if 424 equals=”Regular Issue”]Issue[/if 424][if 424 equals=”Special Issue”]Special Issue[/if 424] [if 424 equals=”Conference”][/if 424] | 02 | |
| Received | 03/04/2025 | |
| Accepted | 09/04/2025 | |
| Published | 25/07/2025 | |
| Retracted | ||
| Publication Time | 113 Days |
n
n
nn
n
Login
PlumX Metrics
n
n
n[if 1746 equals=”Retracted”]n
[/if 1746]nnn
nnn”}]